XML 42 R70.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting (Details) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Mar. 31, 2020
Mar. 31, 2019
Jun. 30, 2019
Consolidated revenue $ 8,156,173     $ 2,377,792     $ 12,771,235 $ 5,604,612  
Consolidated net loss (5,332,305) $ (214,247) $ (4,929,030) (4,495,862) $ (4,657,662) $ (3,446,483) (10,475,582) (12,600,007)  
Total assets 158,953,803           158,953,803   $ 34,721,391
Aytu BioScience                  
Consolidated revenue 4,703,000     2,738,000     9,318,000 5,605,000  
Consolidated net loss (4,421,000)     (4,496,000)     (9,565,000) (12,600,000)  
Total assets 137,825,000           137,825,000   34,721,000
Aytu Consumer Health                  
Consolidated revenue 3,453,000     0     3,453,000 0  
Consolidated net loss (911,000)     $ 0     (911,000) $ 0  
Total assets $ 21,129,000           $ 21,129,000   $ 0